DrugPatentWatch Database Preview
Duchesnay Company Profile
What is the competitive landscape for DUCHESNAY, and what generic alternatives to DUCHESNAY drugs are available?
There are fourteen US patents protecting DUCHESNAY drugs.
There are one hundred and seventy-seven patent family members on DUCHESNAY drugs in fifty-three countries and twelve supplementary protection certificates in ten countries.
Summary for Duchesnay
| International Patents: | 177 |
| US Patents: | 14 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Duchesnay
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | RX | Yes | Yes | 8,642,079 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | RX | Yes | Yes | 9,566,252 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | 9,089,489 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Duchesnay | OSPHENA | ospemifene | TABLET;ORAL | 203505-001 | Feb 26, 2013 | RX | Yes | Yes | 8,236,861 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for DUCHESNAY drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 10 mg/10 mg | ➤ Subscribe | 2013-08-01 |
Non-Orange Book US Patents for Duchesnay
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,984,665 | Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Duchesnay Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2001272243 | ➤ Try a Free Trial |
| Croatia | P20030024 | ➤ Try a Free Trial |
| Estonia | 200300031 | ➤ Try a Free Trial |
| South Korea | 20170046163 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Duchesnay Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 736 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: OSPEMIFENE DANS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; FIRST REGISTRATION: 20150115 |
| /2015 | Austria | ➤ Try a Free Trial | PRODUCT NAME: OSPEMIFEN; REGISTRATION NO/DATE: EU/1/14/978/001-002 20150119 |
| 0150029 00165 | Estonia | ➤ Try a Free Trial | PRODUCT NAME: OSPEMIFEEN;REG NO/DATE: EU/1/14/978 19.01.2015 |
| 2015023,C1713458 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: OSPEMIFENAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/14/978/001, 2015 01 15 EU/1/14/978/002 20150115 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
